Humacyte, Inc. - stock earnings
HUMAW Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -26.0 million USD | ? USD |
| 2023Q2 | -22.7 million USD | ? USD |
| 2023Q1 | -61.8 million USD | ? USD |
| 2022Q4 | 13.6 million USD | ? USD |
| 2022Q3 | -25.4 million USD | 31000 USD |
| 2022Q2 | 92.3 million USD | ? USD |
| 2022Q1 | -16.5 million USD | ? USD |
| 2021Q4 | 42.6 million USD | ? USD |
| 2021Q3 | -31.6 million USD | ? USD |
| 2021Q2 | -17.2 million USD | ? USD |
| 2021Q1 | -20.3 million USD | ? USD |
| 2020Q4 | -16.2 million USD | ? USD |
| 2020Q3 | -17.8 million USD | ? USD |
HUMAW Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -89.4 million USD | ? USD |
| 2022 | 64.2 million USD | 1.6 million USD |
| 2021 | 37.5 million USD | 1.3 million USD |
| 2020 | -68.7 million USD | 1.5 million USD |
| 2019 | -85.4 million USD | 6.2 million USD |
HUMAW
Price: $0.69
52 week price:
Earnings Per Share: -3.16 USD
P/E Ratio: -0.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 31189
Market Capitalization: 385.7 million